NME
Notis-McConarty Edward Portfolio holdings
AUM
$205M
This Quarter Return
+5.52%
1 Year Return
+14.8%
3 Year Return
+72.99%
5 Year Return
+119.96%
10 Year Return
+295.3%
AUM
$174M
AUM Growth
+$174M
(+9.1%)
Cap. Flow
+$6.47M
Cap. Flow
% of AUM
3.72%
Top 10 Holdings %
Top 10 Hldgs %
34.16%
Holding
90
New
1
Increased
40
Reduced
30
Closed
1
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$463K |
| 2 |
Exxon Mobil
XOM
|
$453K |
| 3 |
Canadian National Railway
CNI
|
$441K |
| 4 |
Union Pacific
UNP
|
$429K |
| 5 |
Apple
AAPL
|
$423K |
Top Sells
| 1 |
J.M. Smucker
SJM
|
$1.05M |
| 2 |
Schlumberger
SLB
|
$624K |
| 3 |
Wells Fargo
WFC
|
$612K |
| 4 |
Lowe's Companies
LOW
|
$297K |
| 5 |
Honeywell
HON
|
$276K |
Sector Composition
| 1 | Healthcare | 24.3% |
| 2 | Technology | 23.36% |
| 3 | Industrials | 16.39% |
| 4 | Consumer Staples | 8.32% |
| 5 | Financials | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$204B
| $2.1M | 1.21% |
17,541
+1,460
| +9% | +$175K |
|
27
JPMorgan Chase
JPM
$829B
| $2.07M | 1.19% |
19,327
-505
| -3% | -$54K |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $1.93M | 1.11% |
18,500
+100
| +0.5% | +$10.4K |
|
29
Oracle
ORCL
$635B
| $1.9M | 1.09% |
40,212
+4,250
| +12% | +$201K |
|
|
30
Honeywell
HON
$139B
| $1.66M | 0.96% |
10,849
-1,800
| -14% | -$276K |
|
|
XLNX
31
DELISTED
Xilinx Inc
XLNX
| $1.58M | 0.91% |
23,400
+2,365
| +11% | +$159K |
|
32
NVIDIA
NVDA
$4.24T
| $1.51M | 0.87% |
7,805
+1,815
| +30% | +$351K |
|
|
33
Lowe's Companies
LOW
$145B
| $1.49M | 0.85% |
16,000
-3,200
| -17% | -$297K |
|
34
GE Aerospace
GE
$292B
| $1.48M | 0.85% |
84,755
+4,100
| +5% | +$71.5K |
|
35
Emerson Electric
EMR
$74.3B
| $1.44M | 0.83% |
20,650
-125
| -0.6% | -$8.72K |
|
36
Chevron
CVX
$324B
| $1.43M | 0.82% |
11,380
-200
| -2% | -$25K |
|
37
Illumina
ILMN
$15.8B
| $1.38M | 0.79% |
6,330
| – | – |
|
|
38
Union Pacific
UNP
$133B
| $1.38M | 0.79% |
10,250
+3,200
| +45% | +$429K |
|
39
Qualcomm
QCOM
$173B
| $1.33M | 0.77% |
20,845
-1,200
| -5% | -$76.8K |
|
40
Bristol-Myers Squibb
BMY
$96B
| $1.33M | 0.76% |
21,711
+6,550
| +43% | +$402K |
|
41
DuPont de Nemours
DD
$32.2B
| $1.29M | 0.74% |
18,142
-56
| -0.3% | -$3.99K |
|
42
Merck
MRK
$210B
| $1.29M | 0.74% |
22,830
+3,900
| +21% | +$220K |
|
43
Xylem
XYL
$34.5B
| $1.22M | 0.7% |
17,945
+220
| +1% | +$15K |
|
44
Cisco
CSCO
$274B
| $1.2M | 0.69% |
31,430
-3,000
| -9% | -$115K |
|
45
Stryker
SYK
$150B
| $1.2M | 0.69% |
7,745
-25
| -0.3% | -$3.87K |
|
46
Colgate-Palmolive
CL
$67.9B
| $1.17M | 0.67% |
15,495
-175
| -1% | -$13.2K |
|
47
Diageo
DEO
$62.1B
| $1.16M | 0.67% |
7,965
-440
| -5% | -$64.2K |
|
48
Gilead Sciences
GILD
$140B
| $1.09M | 0.63% |
15,197
| – | – |
|
49
Fortive
FTV
$16.2B
| $998K | 0.57% |
13,792
+833
| +6% | +$60.3K |
|
50
Pembina Pipeline
PBA
$21.9B
| $970K | 0.56% |
26,800
+8,400
| +46% | +$304K |
|